Fact CheckerSign in

NCT07014423Completed

The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

This is a randomized control trial that aims to evaluate the added value of electro-anatomical mapping to improve the quality of pulse field ablation lesions during Atrial fibrillation ablation.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
28 May 2025
Start date
Sept 2025
Primary completion date
Dec 2025
Lead sponsor
University Medical Center Groningen
NCT number
NCT07014423

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From Sept 2025 to the primary completion date, Dec 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • -History of prior Atrial Fibrillation ablation.

Who the study is looking for

  • Diagnosed with Atrial Fibrillation.
  • Planned for ablation with Pulsed Field ablation technology.
  • Able to consent for participation.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Medical Center Groningen
Coordinator of this site? Confirm its status
GroningenNetherlandsUnknown status
Erasmus Medical Center
Coordinator of this site? Confirm its status
RotterdamNetherlandsUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.